Une étude sérieuse et récente ne montre pas de différence sur l'état dépressif entre patients non traités, patients traités pour acné par antibiotique ou patient traités par isotrétinoine - Les patients traités ont cependant une meilleure qualité de vie- particulièrement ceux qui ont une tendance dépressive.
CONCLUSIONS: Treatment of acne improves QoL, particularly in those with more depressive symptoms at the outset. Mood deterioration was not detected, but the possibility of subtle or rare mood effects of isotretinoin cannot be ruled out.
[URL="http://www.ncbi.nlm.nih.gov/pubmed/21137117#"]Br J Dermatol.[/URL] 2010 Dec;163(6):1323-9.
A prospective trial of the effects of isotretinoin on quality of life and depressive symptoms.
[URL="http://www.ncbi.nlm.nih.gov/pubmed?term=%22McGrath%20EJ%22%5BAuthor%5D"]McGrath EJ[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Lovell%20CR%22%5BAuthor%5D"]Lovell CR[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Gillison%20F%22%5BAuthor%5D"]Gillison F[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Darvay%20A%22%5BAuthor%5D"]Darvay A[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Hickey%20JR%22%5BAuthor%5D"]Hickey JR[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Skevington%20SM%22%5BAuthor%5D"]Skevington SM[/URL].
Source
Kinghorn Dermatology Unit, Royal United Hospital, Bath BA1 3NG, UK. [email]ejsefton@doctors.org.uk[/email]
Abstract
BACKGROUND:
Isotretinoin is an efficacious treatment for acne, but has been controversially linked with depression.
OBJECTIVES:
This study aimed to examine the effects of isotretinoin on quality of life(QoL) and depression using a prospective design.
METHODS:
The WHOQOL-BREF QoL measure and Centre for Epidemiological Studies Depression Scale were administered to consecutive outpatients with acne who were prescribed either isotretinoin (n = 65) or antibiotic treatment (n = 31).Patients and physicians rated acne severity independently. Groups were compared at baseline with a matched community sample (n = 94) and measurements repeated at 3 months for treatment groups.
RESULTS:
There were no differences between the three groups at baseline in terms of age, gender, depression or overall QoL. Acne was more severe in the treatment groups (P < 0·001). Depression was negatively correlated with QoL (P < 0·001)and hence was included as a covariate in repeated-measures analyses of QoL.Acne improved over time in both treatment groups (F = 48·2, P < 0·001). There was no detectable deterioration in depression score in either group (F = 1·1, not significant). QoL in the physical and social domains improved (P < 0·001) while psychological and environmental QoL was unchanged over time. The improvement in social QoL was greater in the isotretinoin group (P < 0·05). Those patients with higher baseline depression scores showed greater improvements in physical, psychological and social QoL (P < 0·001).
CONCLUSIONS:
Treatment of acne improves QoL, particularly in those with more depressive symptoms at the outset. Mood deterioration was not detected, but the possibility of subtle or rare mood effects of isotretinoin cannot be ruled out.
L'information ou le conseil en ligne ne sont pas des consultations médicales et ne doivent exonérer ni le médecin ni le patient d'une véritable consultation avec une anamnèse et un examen clinique qui seuls peuvent permettre d'aboutir à un diagnostic et à une prescription.
Dr Philippe Abimelec, Dermatologue